Capecitabine plus oxaliplatin (xelox) in the treatment of chemotherapy-naive patients with metastatic colorectal cancer

被引：0
|
作者：
Emel Yaman
Aytug Uner
Ozlem Er
Ugur Coskun
Suleyman Buyukberber
Mustafa Dikilitas
Mevlude Polat
Deniz Yamac
Ali Osman Kaya
Ramazan Yildiz
Banu Ozturk
Mustafa Benekli
机构：
[1] Gazi University Medical School,Department of Medical Oncology
[2] Erciyes University Medical School,Department of Medical Oncology
来源：
Medical Oncology | 2007年 / 24卷
关键词：
Metastatic colorectal cancer; Oxaliplatin; Capecitabine;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：431 / 435
页数：4
相关论文
共 50 条
  • [21] Chronomodulated Administration of Oxaliplatin plus Capecitabine (XELOX) as First Line Chemotherapy in Metastatic Colorectal Cancer Patients: Phase II Brunch Regimen Study.
    Pilanci, Kezban Nur
    Saglam, Sezer
    Okyar, Alper
    Yucel, Serap
    Kara, Zeliha Pala
    Ordu, Cetin
    Namal, Esat
    Ciftci, Rumeysa
    Koksal, Ulkuhan
    Saglam, Esra Kaytan
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [22] Oxaliplapin and Capecitabine (XELOX) Based Chemotherapy in the Treatment of Metastatic Colorectal Cancer: The Right Choice in Elderly Patients
    Berretta, Massimiliano
    Aprile, Giuseppe
    Nasti, Guglielmo
    Urbani, Martina
    Bearz, Alessandra
    Lutrino, Stefania
    Foltran, Luisa
    Ferrari, Laura
    Talamini, Renato
    Fiorica, Francesco
    Lleshi, Arben
    Canzonieri, Vincenzo
    Lestuzzi, Chiara
    Borsatti, Eugenio
    Fisichella, Rossella
    Tirelli, Umberto
    ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY, 2013, 13 (09) : 1344 - 1353
  • [23] CAPECITABINE AND OXALIPLATIN (XELOX) COMBINATION CHEMOTHERAPY AS FIRST-LINE TREATMENT FOR METASTATIC COLORECTAL CANCER-A PHASE II STUDY
    Tawfik, Hesham
    El-Deen, Hanan Gamal
    ANNALS OF ONCOLOGY, 2012, 23 : 98 - 98
  • [24] Chronomodulated administration of oxaliplatin plus capecitabine (XELOX) as first line chemotherapy in advanced colorectal cancer patients:: phase II study
    Santini, Daniele
    Vincenzi, Bruno
    Schiavon, Gaia
    Di Seri, Marisa
    Virzi, Vladimir
    Spalletta, Bruno
    Caricato, Marco
    Coppola, Roberto
    Tonini, Giuseppe
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2007, 59 (05) : 613 - 620
  • [25] Adjuvant chemotherapy for chemotherapy-naive advanced gastric cancer patients with oxaliplatin plus tegafur versus oxaliplatin plus S-1
    Shu, Zhenbo
    Ding, Dayong
    Li, Yongchao
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2017, 10 (06): : 9322 - 9329
  • [26] Chronomodulated administration of oxaliplatin plus capecitabine (XELOX) as first line chemotherapy in advanced colorectal cancer patients: phase II study
    Daniele Santini
    Bruno Vincenzi
    Gaia Schiavon
    Marisa Di Seri
    Vladimir Virzí
    Bruno Spalletta
    Marco Caricato
    Roberto Coppola
    Giuseppe Tonini
    Cancer Chemotherapy and Pharmacology, 2007, 59 : 613 - 620
  • [27] Subjective sleep and overall survival in chemotherapy-naive patients with metastatic colorectal cancer
    Innominato, Pasquale F.
    Spiegel, David
    Ulusakarya, Ayhan
    Giacchetti, Sylvie
    Bjarnason, Georg A.
    Levi, Francis
    Palesh, Oxana
    SLEEP MEDICINE, 2015, 16 (03) : 391 - 398
  • [28] Capecitabine/oxaliplatin (XELOX) versus XELOX plus bevacizumab (XELOX plus bev) cost-effectiveness for metastatic colorectal cancer (mCRC) in first line treatment: a Brazilian public hospital analysis
    Peria, F. M.
    Ungari, A. Q.
    Dos Santos, F. N.
    Lins-Almeida, T.
    Nunes, A. A.
    ANNALS OF ONCOLOGY, 2016, 27
  • [29] Capecitabine and oxaliplatin (XELOX) as first-line treatment for elderly patients (pts) with advanced/metastatic colorectal cancer (MCRC)
    Salud, A.
    Escudero, P.
    Feliu, J.
    Lopez-Gomez, L.
    Bolanos, M.
    Galan, A.
    Yubero, A.
    Vicent, J. M.
    Losa, F.
    Gonzalez-Baron, M.
    EJC SUPPLEMENTS, 2005, 3 (02): : 190 - 190
  • [30] Capecitabine plus oxaliplatin (XELOX) versus 5-fluorouracil/leucovorin plus oxaliplatin (FOLFOX-6) as first-line treatment for metastatic colorectal cancer
    Ducreux, Michel
    Bennouna, Jaafar
    Hebbar, Mohamed
    Ychou, Marc
    Lledo, Gerard
    Conroy, Thierry
    Adenis, Antoine
    Faroux, Roger
    Rebischung, Christine
    Bergougnoux, Loic
    Kockler, Leila
    Douillard, Jean-Yves
    INTERNATIONAL JOURNAL OF CANCER, 2011, 128 (03) : 682 - 690
12345